{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T17:01:04Z","timestamp":1783702864285,"version":"3.55.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"Taiwan Ministry of Science and Technology","doi-asserted-by":"publisher","award":["110-2314-B-182A-071-MY3"],"award-info":[{"award-number":["110-2314-B-182A-071-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["CMRPG3M216"],"award-info":[{"award-number":["CMRPG3M216"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["CMRPG3N0341"],"award-info":[{"award-number":["CMRPG3N0341"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital Linkou","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006397","name":"National Taiwan Normal University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejphar.2024.176370","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T02:06:47Z","timestamp":1707098807000},"page":"176370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Investigating the therapeutic effects of novel compounds targeting inflammatory IL-1\u03b2 and IL-6 signaling pathways in spinocerebellar ataxia type 3"],"prefix":"10.1016","volume":"967","author":[{"given":"I-Cheng","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Hsuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Wei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te-Hsien","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiung-Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guey-Jen","family":"Lee-Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.176370_bib1","article-title":"Role of mtDNA disturbances in the pathogenesis of Alzheimer's and Parkinson's disease","volume":"91\u201392","author":"Antonyova","year":"2020","journal-title":"DNA Repair"},{"key":"10.1016\/j.ejphar.2024.176370_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.smim.2013.12.004","article-title":"Inhibition of IL-6 family cytokines by SOCS3","volume":"26","author":"Babon","year":"2014","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ejphar.2024.176370_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2024.176370_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134482","article-title":"PARP-1 inhibition is neuroprotective in the R6\/2 mouse model of Huntington's disease","volume":"10","author":"Cardinale","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2024.176370_bib5","article-title":"Aqueous extract of Paeonia lactiflora and paeoniflorin as aggregation reducers targeting chaperones in cell models of spinocerebellar ataxia 3. Evid. Based Complement","volume":"2013","author":"Chang","year":"2013","journal-title":"Alternat. Med."},{"key":"10.1016\/j.ejphar.2024.176370_bib6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuropharm.2014.01.032","article-title":"Aqueous extract of Gardenia jasminoides targeting oxidative stress to reduce polyQ aggregation in cell models of spinocerebellar ataxia 3","volume":"81","author":"Chang","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2024.176370_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.31083\/j.jin.2020.03.112","article-title":"Muramyl dipeptide promotes A\u03b21-42 oligomer production via the NOD2\/p-p38 MAPK\/BACE1 signaling pathway in the SH-SY5Y cells","volume":"19","author":"Chen","year":"2020","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176370_bib8","doi-asserted-by":"crossref","first-page":"23619","DOI":"10.18632\/aging.103700","article-title":"Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation","volume":"12","author":"Chiu","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ejphar.2024.176370_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3058861","article-title":"Novel synthetic coumarin-chalcone derivative (E)-3-(3-(4-(dimethylamino)phenyl)acryloyl)-4-hydroxy-2 H-chromen-2-one activates CREB-mediated neuroprotection in A\u03b2 and tau cell models of Alzheimer's disease","volume":"2021","author":"Chiu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2024.176370_bib10","doi-asserted-by":"crossref","first-page":"7568","DOI":"10.18632\/aging.204306","article-title":"Novel TRKB agonists activate TRKB and downstream ERK and AKT signaling to protect A\u03b2-GFP SH-SY5Y cells against A\u03b2 toxicity","volume":"14","author":"Chiu","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.ejphar.2024.176370_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2024.176370_bib12","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1007\/s00415-013-7051-7","article-title":"Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy","volume":"260","author":"Coelho","year":"2013","journal-title":"J. Neurol."},{"key":"10.1016\/j.ejphar.2024.176370_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2024.176370_bib14","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejphar.2024.176370_bib15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuroscience.2015.01.003","article-title":"Early activation of microglia and astrocytes in mouse models of spinocerebellar ataxia type 1","volume":"289","author":"Cvetanovic","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2024.176370_bib16","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","article-title":"Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice","volume":"61","author":"Dempsey","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2024.176370_bib17","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1128\/MCB.23.18.6469-6483.2003","article-title":"Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis","volume":"23","author":"Doss-Pepe","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2024.176370_bib18","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.3390\/molecules25235533","article-title":"Inhibiting the NLRP3 inflammasome","volume":"25","author":"El-Sharkawy","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2024.176370_bib19","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1523\/JNEUROSCI.21-15-05389.2001","article-title":"Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains","volume":"21","author":"Evert","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176370_bib20","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jnen\/62.10.1006","article-title":"Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3","volume":"62","author":"Evert","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.ejphar.2024.176370_bib21","first-page":"272","article-title":"Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3","volume":"25","author":"Evert","year":"2006","journal-title":"Clin. Neuropathol."},{"key":"10.1016\/j.ejphar.2024.176370_bib22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/1087057105274896","article-title":"Quantitative cell-based high-content screening for vasopressin receptor agonists using Transfluor\u00aetechnology","volume":"10","author":"Ghosh","year":"2005","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejphar.2024.176370_bib23","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/jcmm.14113","article-title":"Conditioned medium from amniotic cells protects striatal degeneration and ameliorates motor deficits in the R6\/2 mouse model of Huntington's disease","volume":"23","author":"Giamp\u00e0","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2024.176370_bib24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3390\/antiox10091450","article-title":"Oxidative stress and neurodegeneration: interconnected processes in polyQ diseases","volume":"10","author":"Gkekas","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejphar.2024.176370_bib25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-\u03b2","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2024.176370_bib26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","article-title":"Microglia in neurodegeneration","volume":"21","author":"Hickman","year":"2018","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176370_bib27","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1021\/jm060642i","article-title":"Structure\u2212brain exposure relationships","volume":"49","author":"Hitchcock","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176370_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5497046","article-title":"Proteostasis failure in neurodegenerative diseases: focus on oxidative stress","volume":"2020","author":"H\u00f6hn","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2024.176370_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ptr.6227","article-title":"Chemo\u2010preventive and therapeutic effect of the dietary flavonoid kaempferol: a comprehensive review","volume":"33","author":"Imran","year":"2019","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2024.176370_bib30","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.3390\/ijms22168800","article-title":"Astrocytes stimulate microglial proliferation and M2 polarization in vitro through crosstalk between astrocytes and microglia","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176370_bib31","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1126\/science.aag2638","article-title":"Multifaceted interactions between adaptive immunity and the central nervous system","volume":"353","author":"Kipnis","year":"2016","journal-title":"Sciences"},{"key":"10.1016\/j.ejphar.2024.176370_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","article-title":"Spinocerebellar ataxia","volume":"5","author":"Klockgether","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2024.176370_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejphar.2024.176370_bib34","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1084\/jem.20181035","article-title":"3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice","volume":"216","author":"Lazic","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2024.176370_bib35","doi-asserted-by":"crossref","first-page":"8622","DOI":"10.1002\/ange.201502789","article-title":"Preparation of furo [3, 2\u2010c] coumarins from 3\u2010cinnamoyl\u20104\u2010hydroxy\u20102H\u2010chromen\u20102\u2010ones and acyl chlorides: a Bu3P\u2010mediated C\u2010acylation\/cyclization sequence","volume":"127","author":"Lee","year":"2015","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejphar.2024.176370_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.202000746","article-title":"Quercetin attenuates atherosclerotic inflammation by inhibiting galectin\u20103\u2010NLRP3 signaling pathway","volume":"65","author":"Li","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.ejphar.2024.176370_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135337","article-title":"ERK activation precedes Purkinje cell loss in mice with spinocerebellar ataxia type 17","volume":"738","author":"Lin","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2024.176370_bib38","article-title":"Neuroprotective action of coumarin derivatives through activation of TRKB-CREB-BDNF pathway and reduction of caspase activity in neuronal cells expressing pro-aggregated tau protein","volume":"23","author":"Lin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176370_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2024.176370_bib40","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0898-6568(04)00027-0","article-title":"Expression of NALP1 in cerebellar granule neurons stimulates apoptosis. Cell","volume":"16","author":"Liu","year":"2004","journal-title":"Signal"},{"key":"10.1016\/j.ejphar.2024.176370_bib41","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1021\/ci500004h","article-title":"AlzPlatform: an Alzheimer's disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research","volume":"54","author":"Liu","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejphar.2024.176370_bib42","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3389\/fimmu.2020.01024","article-title":"Interaction of microglia and astrocytes in the neurovascular unit","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2024.176370_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.conb.2020.02.009","article-title":"Potential benefit of manipulating protein quality control systems in neurodegenerative diseases","volume":"61","author":"Luh","year":"2020","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.ejphar.2024.176370_bib44","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2024.176370_bib45","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jnc.14541","article-title":"Machado-Joseph disease\/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy","volume":"148","author":"Matos","year":"2019","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2024.176370_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104635","article-title":"Pathogenesis of SCA3 and implications for other polyglutamine diseases","volume":"134","author":"McLoughlin","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2024.176370_bib47","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/brain\/awu352","article-title":"Transplantation of cerebellar neural stem cells improves motor coordination and neuropathology in Machado-Joseph disease mice","volume":"138","author":"Mendon\u00e7a","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2024.176370_bib48","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1093\/hmg\/ddz097","article-title":"Ibuprofen enhances synaptic function and neural progenitors proliferation markers and improves neuropathology and motor coordination in Machado\u2013Joseph disease models","volume":"28","author":"Mendon\u00e7a","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejphar.2024.176370_bib49","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/873860","article-title":"The role of the immune system in triplet repeat expansion diseases","volume":"2015","author":"Olejniczak","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ejphar.2024.176370_bib50","first-page":"47","article-title":"Signal transduction pathways activated by the IL-1 receptor\/toll-like receptor superfamily","volume":"270","author":"O'Neill","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.ejphar.2024.176370_bib51","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1021\/jf010586o","article-title":"Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe","volume":"49","author":"Ou","year":"2001","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejphar.2024.176370_bib52","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.3390\/cells9102286","article-title":"Modulation of inflammasome and pyroptosis by olaparib, a PARP-1 inhibitor, in the R6\/2 mouse model of Huntington's disease","volume":"9","author":"Paldino","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2024.176370_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214196","article-title":"3K3A-activated protein C prevents microglia activation, inhibits NLRP3 inflammasome and limits ocular inflammation","volume":"23","author":"Palevski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.176370_bib54","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1021\/jm960803q","article-title":"Synthesis and biological evaluation of the 1,5-dioxy pyrazol class of cyclooxygenase inhibitors: identification of 4-[5-1,4-methyl phenyl 3-trifluromethyl-III-pyrazole-1-yl] benzene sulfonimide (SC-56635 celecoxib)","volume":"40","author":"Penning","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2024.176370_bib55","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0022-3565(24)29317-4","article-title":"Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors","volume":"299","author":"Perregaux","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2024.176370_bib56","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12974-017-0880-z","article-title":"Inhibition of colony-stimulating factor 1 receptor early in disease ameliorates motor deficits in SCA1 mice","volume":"14","author":"Qu","year":"2017","journal-title":"Neuroinflammation"},{"key":"10.1016\/j.ejphar.2024.176370_bib57","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/brain\/awf208","article-title":"Spinocerebellar ataxia type 3 (Machado\u2013Joseph disease): severe destruction of the lateral reticular nucleus","volume":"125","author":"R\u00fcb","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2024.176370_bib58","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41467-019-11441-0","article-title":"Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington's disease","volume":"10","author":"Siew","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2024.176370_bib59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fnins.2014.00315","article-title":"Inflammasomes in neuroinflammation and changes in brain function: a focused review","volume":"8","author":"Singhal","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2024.176370_bib60","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1021\/acsmedchemlett.9b00688","article-title":"Brain permeable tafamidis amide analogs for stabilizing TTR and reducing APP cleavage","volume":"11","author":"Sinha","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2024.176370_bib61","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nbd.2014.09.020","article-title":"A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3\/MJD","volume":"73","author":"Switonski","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2024.176370_bib62","doi-asserted-by":"crossref","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","article-title":"IL-6 in inflammation, immunity, and disease","volume":"6","author":"Tanaka","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ejphar.2024.176370_bib63","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","article-title":"MCC950 closes the active conformation of NLRP3 to an inactive state","volume":"15","author":"Tapia-Abell\u00e1n","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejphar.2024.176370_bib64","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1093\/brain\/awv262","article-title":"Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease","volume":"138","author":"Teixeira-Castro","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.ejphar.2024.176370_bib65","article-title":"Chalcone: a potential scaffold for NLRP3 inflammasome inhibitors","volume":"7","author":"Thapa","year":"2023","journal-title":"Eur. J. Med. Chem. Rep."},{"key":"10.1016\/j.ejphar.2024.176370_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000354","article-title":"MCC950\/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition","volume":"17","author":"Vande Walle","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.ejphar.2024.176370_bib67","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature25158","article-title":"Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer's disease","volume":"552","author":"Venegas","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2024.176370_bib68","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201810248","article-title":"Inflammasomes in neuroinflammatory and neurodegenerative diseases","volume":"11","author":"Voet","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejphar.2024.176370_bib69","first-page":"97","article-title":"Treatment of neurodegenerative ataxias with intravenous immune globulin","volume":"4","author":"Zesiewicz","year":"2014","journal-title":"J. Neurol. Res."},{"key":"10.1016\/j.ejphar.2024.176370_bib70","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6750-11-10","article-title":"Flavonoid engineering of flax potentiate its biotechnological application","volume":"11","author":"\u017buk","year":"2011","journal-title":"BMC Biotechnol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992400058X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001429992400058X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:28:14Z","timestamp":1757978894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001429992400058X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":70,"alternative-id":["S001429992400058X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176370","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigating the therapeutic effects of novel compounds targeting inflammatory IL-1\u03b2 and IL-6 signaling pathways in spinocerebellar ataxia type 3","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.176370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"176370"}}